ESTRO 2023 - Abstract Book

S1140

Digital Posters

ESTRO 2023

Results Between 2015-2021, eighty-four patients who had received radical CRT for LACC were included in this study.

The incidence of ≥ grade 3 toxicity in Hb, WCC, NC, LC and PC were 26%, 36%, 15%, 88% and 5% respectively.

Multiple logistic regression analysis demonstrated PB V45Gy with HR of 1.2 (95% CI 1.0-1.4), LS V40Gy with HR of 1.1 (95% CI 1.0-1.2), PB minimum dose with HR of 1.3 (95% CI 1.0-1.6) were independent factors (p<0.05) in the development of ≥ grade 2 Hb, WCC and PC toxicity respectively. LS maximum dose was associated with grade 4 LC toxicity with HR of 1.1 (95% CI 1.0-1.2). No statistically significant factors were identified to correlate with risk of ≥ grade 2 NC.

Conclusion